🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Astera Labs staock rated a Buy on strong earnings, growth outlook

EditorAhmed Abdulazez Abdulkadir
Published 05/11/2024, 12:30
ALAB
-

On Tuesday, Stifel maintained a positive stance on Astera Labs (NASDAQ:ALAB), increasing the price target to $100 from $80 while keeping a Buy rating on the stock. The firm's decision followed Astera Labs' impressive third-quarter performance and optimistic projections for the fourth quarter of 2024.

Astera Labs reported a robust third-quarter revenue beat, with a 16.0% increase over Stifel's estimates and a 47.2% rise quarter over quarter. The company's fourth-quarter 2024 earnings estimate was also raised significantly, showing a 17.2% increase against Stifel's expectations and a 13.2% growth quarter over quarter.

The company's revenue is expected to continue its upward trajectory into the calendar year 2025, driven by a diverse range of products and increasing content across multiple customers. Astera Labs is expanding its customer base and production for its Aries retimer programs, which include digital signal processors and smart cable modules. This expansion is extending from merchant GPU suppliers to hyperscalers' internal AI accelerators.

Additionally, the firm noted an increasing contribution from Astera Labs' Taurus smart cable module, particularly in the 200G/400G segments. Furthermore, the pre-production phase of the Leo CXL memory controller is underway, aligning with the launch of next-generation server CPUs. Astera Labs is also preparing for the initial pre-production of its Scorpio PCIe Gen 6 switch, with the P-Series expected in the second half of the calendar year 2025 and the X-Series slated for 2026, based on already secured designs.

The revised 12-month price target of $100 is based on a 28.5x enterprise value to sales (EV/S) multiple of Stifel's increased calendar year 2025 earnings estimate, which has been raised by 17.5% and reflects a 52.4% year-over-year growth. The valuation also considers the company's unique profitability and organic growth profile, which includes net gross margins and operating margins of 70% and 40%, respectively, and a projected 50%+ compound annual growth rate over five years.

In other recent news, Astera Labs reported robust third-quarter results, with an adjusted earnings per share of $0.23 and a revenue of $113.1 million. This marks the fifth consecutive quarter of record sales for the company, with a revenue increase of 206% YoY and 47% sequentially. Astera Labs also issued strong guidance for the fourth quarter, projecting revenue between $126 million and $130 million, significantly above the consensus estimate, and a non-GAAP EPS of $0.25 to $0.26.

The company's strong performance and optimistic outlook are driven by expanding market opportunities, particularly the introduction of new Scorpio Fabric Switches. These developments are increasing Astera Labs' dollar content in AI platforms. Furthermore, the company reported a non-GAAP gross margin of 77.8% for the third quarter and a non-GAAP operating income of $36.6 million.

Astera Labs also made strategic moves during the quarter, introducing a new portfolio of Scorpio Smart Fabric Switches designed for AI infrastructure at cloud scale. The company also joined the Ultra Accelerator Link Consortium as a promoting member on the Board of Directors, positioning itself to contribute to the development of UALink technology for high-speed AI accelerator connectivity. These are all recent developments in the company's operations.

InvestingPro Insights

Astera Labs' impressive performance and optimistic projections are further supported by real-time data and insights from InvestingPro. The company's market capitalization stands at $10.91 billion, reflecting investor confidence in its growth potential. Astera Labs has demonstrated remarkable revenue growth, with a staggering 619.03% increase in quarterly revenue as of Q2 2024. This aligns with the article's mention of the company's robust third-quarter performance and upward trajectory in revenue.

InvestingPro Tips highlight that Astera Labs holds more cash than debt on its balance sheet, indicating a strong financial position. This solid foundation supports the company's expansion plans across various product lines, as discussed in the article. Additionally, analysts anticipate sales growth in the current year, corroborating Stifel's positive outlook on the company's future performance.

It's worth noting that Astera Labs boasts impressive gross profit margins of 77.33% for the last twelve months as of Q2 2024. This aligns with Stifel's projection of 70% net gross margins, underlining the company's efficiency in managing costs while scaling its operations.

For investors seeking more comprehensive insights, InvestingPro offers 12 additional tips for Astera Labs, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.